Real-time enrollment status for this myelodysplastic/myeloproliferative neoplasm clinical trial
Current Status
Recruiting
Checked: October 15, 2026 at 2:33 AM UTC
| NCT Number | NCT07228624 |
| Recruiting Status | Recruiting |
| Condition | Myelodysplastic/Myeloproliferative Neoplasm |
| Phase | PHASE2 |
| Target Enrollment | 50 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Fred Hutchinson Cancer Center |
| Last Updated on CT.gov | August 19, 2026 (Aug 19, 2026) |
As of October 15, 2026: Clinical trial NCT07228624 is currently recruiting participants. This phase2 study for myelodysplastic/myeloproliferative neoplasm is actively seeking new participants at 1 location across the United States. The study is sponsored by Fred Hutchinson Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07228624 is actively recruiting participants as of October 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07228624 was last updated Aug 19, 2026 (August 19, 2026). HelloStudys verifies this status automatically.